Brod, M., Lee, K. W., & Rasmussen, M. H. (2020). SAT-091 First Report of Disease-Specific Patient-Reported Outcomes from a Randomized Phase 2 Trial of Once-Weekly Somapacitan vs Daily GH in Children with GHD. J Endocr Soc.
Chicago Style citaatBrod, Meryl, Kai Wai Lee, en Michael Højby Rasmussen. "SAT-091 First Report of Disease-Specific Patient-Reported Outcomes From a Randomized Phase 2 Trial of Once-Weekly Somapacitan Vs Daily GH in Children With GHD." J Endocr Soc 2020.
MLA citatieBrod, Meryl, Kai Wai Lee, en Michael Højby Rasmussen. "SAT-091 First Report of Disease-Specific Patient-Reported Outcomes From a Randomized Phase 2 Trial of Once-Weekly Somapacitan Vs Daily GH in Children With GHD." J Endocr Soc 2020.
Let op: Deze citaties zijn niet altijd 100% accuraat.